COFFEE HOLDING CO INC (JVA)

US1921761052 - Common Stock

1.46  -0.08 (-5.19%)

Fundamental Rating

3

Taking everything into account, JVA scores 3 out of 10 in our fundamental rating. JVA was compared to 92 industry peers in the Food Products industry. JVA has a great financial health rating, but its profitability evaluates not so good. JVA is valued expensive and it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

In the past year JVA was profitable.
JVA had a positive operating cash flow in the past year.
In the past 5 years JVA reported 4 times negative net income.
In multiple years JVA reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.13%, JVA is in line with its industry, outperforming 46.15% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.20%, JVA is in line with its industry, outperforming 47.25% of the companies in the same industry.
JVA's Return On Invested Capital of 0.28% is in line compared to the rest of the industry. JVA outperforms 41.76% of its industry peers.
Industry RankSector Rank
ROA 0.13%
ROE 0.2%
ROIC 0.28%
ROA(3y)-2.55%
ROA(5y)-1.63%
ROE(3y)-4.62%
ROE(5y)-2.92%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

JVA has a Profit Margin of 0.07%. This is comparable to the rest of the industry: JVA outperforms 46.15% of its industry peers.
With a Operating Margin value of 0.14%, JVA perfoms like the industry average, outperforming 41.76% of the companies in the same industry.
JVA has a Gross Margin (17.47%) which is comparable to the rest of the industry.
JVA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.14%
PM (TTM) 0.07%
GM 17.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.79%
GM growth 5Y-1.34%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JVA is destroying value.
The number of shares outstanding for JVA remains at a similar level compared to 1 year ago.
JVA has more shares outstanding than it did 5 years ago.
JVA has a worse debt/assets ratio than last year.

2.2 Solvency

JVA has an Altman-Z score of 3.22. This indicates that JVA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.22, JVA is doing good in the industry, outperforming 75.82% of the companies in the same industry.
JVA has a debt to FCF ratio of 2.63. This is a good value and a sign of high solvency as JVA would need 2.63 years to pay back of all of its debts.
JVA has a better Debt to FCF ratio (2.63) than 80.22% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that JVA is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, JVA belongs to the best of the industry, outperforming 91.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.63
Altman-Z 3.22
ROIC/WACC0.04
WACC6.75%

2.3 Liquidity

A Current Ratio of 2.76 indicates that JVA has no problem at all paying its short term obligations.
JVA has a Current ratio of 2.76. This is amongst the best in the industry. JVA outperforms 82.42% of its industry peers.
A Quick Ratio of 1.18 indicates that JVA should not have too much problems paying its short term obligations.
The Quick ratio of JVA (1.18) is better than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 1.18

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.39% over the past year.
The Revenue has been growing slightly by 3.05% in the past year.
The Revenue has been decreasing by -5.55% on average over the past years.
EPS 1Y (TTM)101.39%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q168.32%
Revenue 1Y (TTM)3.05%
Revenue growth 3Y1.09%
Revenue growth 5Y-5.55%
Revenue growth Q2Q6.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 146.00, which means the current valuation is very expensive for JVA.
JVA's Price/Earnings is on the same level as the industry average.
JVA is valuated expensively when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 146
Fwd PE N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as JVA.
93.41% of the companies in the same industry are more expensive than JVA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.66
EV/EBITDA 15.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

JVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COFFEE HOLDING CO INC

NASDAQ:JVA (5/2/2024, 7:03:00 PM)

1.46

-0.08 (-5.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.34M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 146
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 0.2%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.14%
PM (TTM) 0.07%
GM 17.47%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.76
Quick Ratio 1.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)101.39%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.05%
Revenue growth 3Y1.09%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y